PIASA welcomes 2011/2012 Executive Council and president

Pearce has over 27 years' experience in the pharmaceutical industry, having worked for multinational companies in South Africa, the United States and the United Kingdom. His experience within the multinational pharmaceutical industry includes sales, marketing, clinical research, production and business development.

Joining Pearce on the industry body's management council is Dr Jonathan Louw (Adcock Ingram Healthcare), Pierre Bosch (Alcon Laboratories) and Steve Speller (Servier Laboratories).

Other members on the executive council for 2011/2012 include:

• Laura Engelbrecht Joubert, Abbott Laboratories.
  
• Guni Goolab, AstraZeneca Pharmaceuticals.
  
• Richard de Chastelain, Bayer Healthcare Pharmaceuticals.
  
• Jenny Wright, Galderma Laboratories.
  
• Kobus Venter, Janssen.
  
• Magriet de Wet, Key Oncologics.
  
• Klaus Boehm, Merck.
  
• Timothy Kedijang, Novo Nordisk.
  
• Amanda Wilde, Umsinsi Health Care.

Ashley Pearce, managing director, MSD, has been re-elected president of the Pharmaceutical Industry Association of SA for the 2011/2012 year.

Members of the Pharmaceutical Industry Association (PIASA) Exco for 2011/2012, pictured here: (Back row / left to right): Pierre Bosch, general manager, Alcon Laboratories; Kobus Venter, managing director, Janssen. (Middle row/ left to right): Laura Engelbrecht Joubert, general manager, Abbott Laboratories; Magriet de Wet, managing director, Key Oncologics; Amanda Wilde, managing director, Umsinsi Health Care. (Front Row / left to right): Ashley Pearce, Managing Director, MSD (PIASA president); Jenny Wright, managing director, Galderma Laboratories; Dr Guni Goolab, chief executive officer, AstraZeneca Pharmaceuticals; Dr Jonathan Louw, chief executive officer, Adcock Ingram Healthcare.

Exco members not pictured here: Steve Speller, chief executive officer, Servier Laboratories; Richard de Chastelain, country div. head, Bayer Healthcare Pharmaceuticals ; Klaus Boehm, managing director, Merck; Timothy Kedijang, general manager, Novo Nordisk.